Administration of gadolinium-based contrast agents in MR angiography.
Lin
Kai
K
D003287:Contrast Media / Q000009:adverse effects*; D017277:Drug Approval; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D018810:Magnetic Resonance Angiography; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
D003287:Contrast Media; D005682:Gadolinium